Target engagement imaging of PARP inhibitors in small-cell lung cancer
Treatment of small-cell lung cancer remains a challenge due to multiple mechanisms of resistance to current therapies; measuring patient response is crucial in adapting and choosing adequate treatment. Here the authors develop a strategy to visualise in vivo dynamics of a class of widely used PARP i...
Enregistré dans:
Auteurs principaux: | Brandon Carney, Susanne Kossatz, Benjamin H. Lok, Valentina Schneeberger, Kishore K. Gangangari, Naga Vara Kishore Pillarsetty, Wolfgang A. Weber, Charles M. Rudin, John T. Poirier, Thomas Reiner |
---|---|
Format: | article |
Langue: | EN |
Publié: |
Nature Portfolio
2018
|
Sujets: | |
Accès en ligne: | https://doaj.org/article/e625a8f0d4ae4e3f93d027d2afb43df5 |
Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
Documents similaires
-
Serine-linked PARP1 auto-modification controls PARP inhibitor response
par: Evgeniia Prokhorova, et autres
Publié: (2021) -
In vitro analysis of PARP inhibitor nanoformulations
par: Baldwin P, et autres
Publié: (2018) -
PARP Inhibitors in Combination with Radiotherapy: To Do or Not to Do?
par: Amelia Barcellini, et autres
Publié: (2021) -
PARP Inhibitors and Haematological Malignancies—Friend or Foe?
par: Kathryn A. Skelding, et autres
Publié: (2021) -
Combining PARP with ATR inhibition overcomes PARP inhibitor and platinum resistance in ovarian cancer models
par: Hyoung Kim, et autres
Publié: (2020)